Zobrazeno 1 - 10
of 40
pro vyhledávání: '"E. A. Baryakh"'
Autor:
T. S. Chudnova, E. A. Baryakh, M. S. Litvinenko, T. N. Tolstykh, O. L. Kochneva, E. Y. Grishina, E. N. Misyurina, K. V. Yatskov, E. I. Zhelnova, Y. Y. Polyakov, K. V. Kaluzhskaya
Publikováno v:
Онкогематология, Vol 17, Iss 2, Pp 107-120 (2022)
In the era of COVID-19, the chemotherapy of patients with hematological malignancies has become the cornerstone in hematology. Secondary immunodeficiency as a result of hemoblastosis, predisposes to a more severe course of coronavirus infection, and
Externí odkaz:
https://doaj.org/article/4193169dc7fd4d628f4896e9cce3fcb9
Autor:
E. S. Nesterova, S. K. Kravchenko, A. M. Kovrigina, E. G. Gemdzhian, L. V. Plastinina, Ya. K. Mangasarova, F. E. Babaeva, A. E. Misyurina, O. V. Margolin, A. U. Magomedova, V. I. Vorobiev, D. S. Maryin, E. A. Baryakh, Yu. Yu. Polyakov, P. A. Zeynalova, E. M. Volodicheva, N. N. Glonina, N. V. Minaeva, G. A. Davydova, V. G. Savchenko
Publikováno v:
Онкогематология, Vol 13, Iss 3, Pp 10-24 (2018)
Background. Follicular lymphoma (FL) is the most common type of indolent lymphomas and accounts for 20–30 % of all non-Hodgkin’s lymphomas detected. High risk of recurrence and elderly patients make it difficult to choose induction therapy for FL
Externí odkaz:
https://doaj.org/article/cf0dfc1037f240a49382053175c77ec2
Autor:
E. A. Baryakh
Publikováno v:
Онкогематология, Vol 12, Iss 2, Pp 8-13 (2017)
Hodgkin lymphoma (HL) represents one of the great success stories in hematology going from a uniformly fatal disease; to one that is curable in the vast majority of cases. Despite this success; approximately 5–10 % HL patients are refractory to ini
Externí odkaz:
https://doaj.org/article/fbcd4745866f4976927ca50449739905
Publikováno v:
Терапевтический архив, Vol 87, Iss 4, Pp 91-97 (2015)
B-cell lymphoma that is unclassifiable and intermediate between diffuse large B-cell lymphoma (DLBCL) and Burkitt’s lymphoma (BL) — (UBL) is an aggressive lymphoma that has simultaneously morphological, immunophenotypical, and cytogenetic signs o
Externí odkaz:
https://doaj.org/article/95572ecab73a475e8d62563f06570295
Autor:
T S Konstantinova, Vladimir I. Vorobyev, Dmitry V. Motorin, Vladislav O. Sarzhevsky, Irina V. Poddubnaya, E A Baryakh, K. D. Kaplanov, Nikolay V. Zhukov, Vadim Ptushkin, Gayane Tumyan, E. A. Demina
Publikováno v:
Современная онкология, Vol 22, Iss 2, Pp 52-55 (2020)
Relevance. COVID-19 pandemic currently has a significant negative impact on the treatment of patients with oncological pathology, including patients with classic Hodgkin lymphoma. Generalized data on publications on the impact of concomitant patholog
Autor:
E S Nesterova, S K Kravchenko, E A Baryakh, A E Misyurina, Ya K Mangasarova, V I Vorobev, N G Chernova, E G Gemdzhian, V G Savchenko
Publikováno v:
Современная онкология, Vol 18, Iss 5, Pp 31-32 (2016)
The purpose of the study was to evaluate high-dose chemotherapy efficacy with the next autologous stem cells transplantation (ASCT) in first-line treatment of follicular lymphoma (FL) patients with unfavorable prognosis factors. 43 FL patients with u
Externí odkaz:
https://doaj.org/article/f7a4df9734fe4d4587b77b158167ef61
Autor:
A I Vorobiev, A E Misyurina, L V Plastinina, T N Obukhova, Alla M. Kovrigina, V. A. Misyurin, E A Baryakh, Aminat U. Magomedova, Kravchenko Sk, A. V. Misyurin, L A Grebenuk, F.E. Babaeva
Publikováno v:
Терапевтический архив, Vol 91, Iss 7, Pp 52-62 (2019)
Aim of the issue was to compare clinical characteristics and treatment results of patients with follicular lymphoma (FL) with translocations involving loci of c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes and patients with high - grade B-cell lymphom
Autor:
S V Semochkin, E. I. Zhelnova, N. A. Aref’eva, D. O. Sinyavkin, K. V. Yatskov, O. N. Kotenko, E.N. Misyurina, M.A. Lysenko, I. V. Samsonova, D. E. Gagloeva, E A Baryakh, T. N. Tolstykh, E. V. Yurova, A. I. Ushakova
Publikováno v:
Bulletin of Experimental Biology and Medicine. 167:267-271
Prognostic value of N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP) was analyzed in patients with multiple myeloma complicated by dialysisdependent renal failure. The prospective study included 20 patients with newly
Autor:
A. V. Misyurin, GenoTekhnologiya, letiya Moskvy str., Moscow, Russian Federation, Alla M. Kovrigina, E A Baryakh, Aminat U. Magomedova, F.E. Babaeva, V. A. Misyurin, A E Misyurina, S K Kravchenko
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 3, Pp 263-270 (2019)
Background. TP53 gene mutations impede cell apoptosis and lead to additional oncogenic events contributing to tumor progression. Aim. To assess TP53 gene mutation rate in patients with high-grade B-cell lymphoma double-hit (HGBCL DH) and not otherwis
Autor:
Diana D. Ivanova, Konstantin V. Yatskov, Yuri Yu. Polyakov, Ksenia V. Kaluzhskaya, Inna V. Samsonova, M.A. Lysenko, Tatyana S. Chudnova, Denis A. Fedorenko, Eduard G. Gemdzhian, Olga L. Kochneva, E A Baryakh, Elena N. Misyurina, Evgenia I. Zhelnova
Publikováno v:
Blood
Background: According to published data, the risk of coronavirus infection (COVID-19) in patients with malignancies is 5 times higher than in those without malignancies. Objective: To evaluate in-hospital overall survival in hematological patients wi